503 related articles for article (PubMed ID: 35530153)
1. Impairment of the autophagy-lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential.
Zhang W; Xu C; Sun J; Shen HM; Wang J; Yang C
Acta Pharm Sin B; 2022 Mar; 12(3):1019-1040. PubMed ID: 35530153
[TBL] [Abstract][Full Text] [Related]
2. Celastrol, a TFEB (transcription factor EB) agonist, is a promising drug candidate for Alzheimer disease.
Zhang W; Wang J; Yang C
Autophagy; 2022 Jul; 18(7):1740-1742. PubMed ID: 35253615
[TBL] [Abstract][Full Text] [Related]
3. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
Reddy PH; Oliver DM
Cells; 2019 May; 8(5):. PubMed ID: 31121890
[TBL] [Abstract][Full Text] [Related]
4. Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress.
Chambraud B; Daguinot C; Guillemeau K; Genet M; Dounane O; Meduri G; Poüs C; Baulieu EE; Giustiniani J
Autophagy; 2021 Nov; 17(11):3491-3510. PubMed ID: 33459145
[TBL] [Abstract][Full Text] [Related]
5. Autophagy Modulation in Aggresome Formation: Emerging Implications and Treatments of Alzheimer's Disease.
Rahman MA; Rahman MDH; Mamun-Or-Rashid ANM; Hwang H; Chung S; Kim B; Rhim H
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625764
[TBL] [Abstract][Full Text] [Related]
6. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models.
Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M
Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease-related misfolded proteins and dysfunctional organelles on autophagy menu.
Correia SC; Resende R; Moreira PI; Pereira CM
DNA Cell Biol; 2015 Apr; 34(4):261-73. PubMed ID: 25664381
[TBL] [Abstract][Full Text] [Related]
8. Autophagy in Alzheimer's disease pathogenesis: Therapeutic potential and future perspectives.
Zhang Z; Yang X; Song YQ; Tu J
Ageing Res Rev; 2021 Dec; 72():101464. PubMed ID: 34551326
[TBL] [Abstract][Full Text] [Related]
9. The Implications of Autophagy in Alzheimer's Disease.
Hamano T; Hayashi K; Shirafuji N; Nakamoto Y
Curr Alzheimer Res; 2018; 15(14):1283-1296. PubMed ID: 30289076
[TBL] [Abstract][Full Text] [Related]
10. Autophagic dysfunction in Alzheimer's disease: Cellular and molecular mechanistic approaches to halt Alzheimer's pathogenesis.
Uddin MS; Mamun AA; Labu ZK; Hidalgo-Lanussa O; Barreto GE; Ashraf GM
J Cell Physiol; 2019 Jun; 234(6):8094-8112. PubMed ID: 30362531
[TBL] [Abstract][Full Text] [Related]
11. Autophagy and Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Implications.
Uddin MS; Stachowiak A; Mamun AA; Tzvetkov NT; Takeda S; Atanasov AG; Bergantin LB; Abdel-Daim MM; Stankiewicz AM
Front Aging Neurosci; 2018; 10():04. PubMed ID: 29441009
[TBL] [Abstract][Full Text] [Related]
12. Targeting autophagy in Alzheimer's disease: Animal models and mechanisms.
Zhang XW; Zhu XX; Tang DS; Lu JH
Zool Res; 2023 Nov; 44(6):1132-1145. PubMed ID: 37963840
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
14. Electroacupuncture ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB).
Zheng X; Lin W; Jiang Y; Lu K; Wei W; Huo Q; Cui S; Yang X; Li M; Xu N; Tang C; Song JX
Autophagy; 2021 Nov; 17(11):3833-3847. PubMed ID: 33622188
[TBL] [Abstract][Full Text] [Related]
15. The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer's disease.
Zhang Y; Chen X; Zhao Y; Ponnusamy M; Liu Y
Rev Neurosci; 2017 Nov; 28(8):861-868. PubMed ID: 28704199
[TBL] [Abstract][Full Text] [Related]
16. Urolithin A improves Alzheimer's disease cognition and restores mitophagy and lysosomal functions.
Hou Y; Chu X; Park JH; Zhu Q; Hussain M; Li Z; Madsen HB; Yang B; Wei Y; Wang Y; Fang EF; Croteau DL; Bohr VA
Alzheimers Dement; 2024 Jun; 20(6):4212-4233. PubMed ID: 38753870
[TBL] [Abstract][Full Text] [Related]
17. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer's disease.
Roca-Agujetas V; Barbero-Camps E; de Dios C; Podlesniy P; Abadin X; Morales A; Marí M; Trullàs R; Colell A
Mol Neurodegener; 2021 Mar; 16(1):15. PubMed ID: 33685483
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Autophagy as a Therapeutic Target for Alzheimer's Disease.
Steele JW; Fan E; Kelahmetoglu Y; Tian Y; Bustos V
Postdoc J; 2013 Feb; 1(2):21-34. PubMed ID: 28286801
[TBL] [Abstract][Full Text] [Related]
20. Mitophagy and NAD
Fang EF
Autophagy; 2019 Jun; 15(6):1112-1114. PubMed ID: 30922179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
